Related Articles
Semi‑random mutagenesis profile of BCR‑ABL during imatinib resistance acquirement in K562 cells
Nilotinib rapidly reverses breakpoint cluster region-Abelson oncogene fusion gene and M244V mutations in a patient with chronic myelogenous leukemia: A case report
Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway
β‑catenin inhibitors ICG‑001 and pyrvinium sensitize bortezomib‑resistant multiple myeloma cells to bortezomib
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells